CHONGQING, China, Nov. 6, 2025 /PRNewswire/ — On November 5, SERES Group (stock code: 9927.HK) was officially listed on the Main Board of the Hong Kong Stock Exchange. With this milestone, SERES is now the first Chinese luxury new energy vehicle (NEV) maker to be listed on both the A-share and H-share markets. It is the largest IPO ever by a Chinese automaker and also the world’s largest automaker IPO so far this year.

This successful Hong Kong listing provides SERES with a new international platform for raising capital and supporting long-term growth as well as a solid foundation for the company’s global strategy. More importantly, it establishes a new model for Chinese automakers expanding overseas, combining technological innovation with financial prowess.

Since the launch of SERES’ Hong Kong IPO on October 27, investor enthusiasm has surged. The Hong Kong public offering was oversubscribed by 133 times, raising over HK$170 billion in financing. Approximately 70% of the proceeds will go toward research and development, and roughly 20% will support the expansion of diversified new marketing channels, overseas sales, and charging network services.

Notably, the offering attracted 22 cornerstone investors, including the Chongqing Industrial Mother Fund (Chongqing Industrial Investment Fund of Funds) (FoF), the Linyuan Fund, the GF Fund, Schroders, China Post Wealth, and Xingyu Hong Kong, highlighting broad recognition from global capital markets of SERES’ strong growth prospects and high-quality development. This strong investor backing is expected to drive a re-rating of the company’s valuation and establish a new benchmark for SERES’ investment value, further enhancing its financing capacity and capital efficiency.

A leading player in China’s premium NEV sector, SERES is already expanding its global footprint, with operations now covering multiple countries across Europe, the Middle East, the Americas, and Africa. In Europe alone, SERES has successfully entered key markets such as Norway, Germany, the U.K., and Switzerland, marking the initial phase of its global expansion. Powered by the dual “A+H” capital platform, SERES will continue to drive technological innovation, enhance brand value, and expand its presence globally.

Focused on Premium Smart Electric Vehicles, Building a Moat of Technical Expertise

As a technology-driven company with a focus on NEVs, SERES has committed itself to the premium intelligent electric vehicle market. To date, the AITO lineup, with its M9, M8, M7, and M5 models, has received strong market recognition and customer loyalty, with total deliveries surpassing 800,000 units.

Staying true to its philosophy of “Intelligence Redefining Luxury”, SERES is deeply committed to technological innovation that produces safe, software-defined vehicles. Thanks to its substantial investments in research and development, the company has built a strong moat of technical expertise with innovations, like its MF Technology Platform, Super Range Extender, and Intelligent Safety technology.

Looking ahead, SERES will continue to embrace software-defined vehicles, powering its growth with innovation, driven by user needs, and expanding on the global stage. The company is poised to further strengthen its leadership in the premium NEV segment and drive China’s auto industry into a new era of high-quality development.

• Comau has delivered a fully automated body-in-white welding and material handling solution for Foton Daimler’s next-generation A6 platform for heavy-duty trucks
• Designed for flexibility and scale, the system supports co-line production of 66 vehicle variants
• The innovative solution enables an annual production capacity of up to 120,000 units with an OEE of more than 90%

SHANGHAI, Nov. 6, 2025 /PRNewswire/ — Comau has reinforced its longstanding collaboration with Beijing Foton Daimler Automotive Co., Ltd. (BFDA) by developing and delivering a state-of-the-art, fully automated body-in-white solution to support BFDA’s new A6 platform. The production line, designed for Foton Daimler’s premium heavy-duty trucks, reflects Comau’s commitment to helping its customers achieve modular production, reduced time-to-market, and greater manufacturing flexibility.

With a focus on productivity, achieved through flexible and adaptable operations, Comau’s solution spans the complete body-in-white welding process. From floor and side bodies to roofs and doors, the highly automated system manages complex configurations with ease. The platform, which spans 18 base body types and covers the full range of Foton Auman vehicles, is currently handling 66 vehicle variants with built-in scalability to support future growth.

Comau’s advanced automation allows BFDA to streamline production, achieve an Overall Equipment Effectiveness (OEE) of more than 90% and ensure consistent quality across all its models. Such results are further supported through the centralized control system, which is integrated with key factory software platforms and enables real-time process monitoring and fast, data-driven decisions. Thanks to intelligent quality assurance and rapid model changeover capabilities, the system enhances end-to-end visibility and ensures high first-pass yield rates.

With a projected output of 120,000 trucks per year, the solution supports BFDA’s strategic vision to lead the Chinese market with localized, energy-efficient production of premium trucks. It also reinforces Comau’s leadership in advanced welding automation for industrial, heavy duty and commercial vehicles of all sizes.

“As China’s commercial vehicle sector evolves, the ability to combine flexibility with high-volume production is critical,” said Jeff Yuan, Comau APAC Leader. “This project demonstrates our ability to deliver real-world, high-impact automation—helping customers scale efficiently while adapting to market demands.”

The deployment strengthens Comau’s position in Asia and underscores its commitment to enabling intelligent, flexible, and sustainable manufacturing across global markets.

SINGAPORE, Nov. 6, 2025 /PRNewswire/ — Klook, Asia’s leading platform for travel and experiences, announces two key appointments to its executive leadership team — Daniel Kao as Senior Vice President (SVP) of Product & Technology and Jakii Chu as Senior Vice President (SVP) of Growth Marketing.

“The concurrent arrival of Daniel and Jakii marks a powerful accelerator for Klook’s next growth chapter,” says Ethan Lin, CEO & Co-founder at Klook. “Both are global citizens and seasoned leaders, with deep experience across Asia and the U.S., bringing a rare blend of international scale and regional insight. Their combined expertise in product scaling and data-driven growth marketing will create strong synergies as they collaborate to advance our marketing technology stack.”

Driving Product and Technology Excellence

Daniel Kao is a veteran technology leader with 30 years of experience building and scaling world-class consumer internet platforms. His previous roles include Chief Technology Officer at VIP.com and Director of Site Operations and Quality Engineering at eBay.

At Klook, Daniel will focus on strengthening our product and technology leadership to deliver innovation at a sustainable scale. His priority is to elevate the end-to-end consumer experience and harness data and AI capabilities to drive efficiency and customer delight.

“Having led technology teams at global e-commerce and internet companies across the world, I’m excited to bring that experience to Klook,” says Daniel. “Klook is already redefining how people discover and book experiences, and I see tremendous opportunity to blend global best practices, data, and AI to scale that impact further.”

Accelerating Data-Driven Growth Marketing

Jakii Chu brings 25 years of marketing experience to the table, with a career built at the heart of top Silicon Valley companies. She previously served as Chief Marketing Officer at Instacart, SVP of eCommerce at Fanatics, and Chief Operating Officer of Shipping at eBay, where she shaped the growth engines of billion-dollar global businesses.

At Klook, Jakii will spearhead the company’s performance marketing transformation, focusing on leveraging AI innovation to build a scalable, integrated marketing technology stack. She will also strengthen integrated analytics capabilities to power faster and smarter decision-making across the organization.

“I thrive on making sense of complexity through data, then using those insights to design and implement high-impact marketing strategies that drive sustainable growth,” says Jakii. “Klook’s marketing flywheel is already incredibly comprehensive for its current scale, and I’m excited to work with the team to propel it to the next level of growth.”

About Klook
Klook is Asia’s leading platform for experiences and travel services. We curate quality experiences ranging from attractions and tours to local transport and experiential stays, in around 4,200 destinations globally. Founded in 2014, we are here to inspire and enable more moments of joy for travelers anytime, anywhere.

• Two new specially designed certification programmes will train doctors, nurses and technical specialists across the region in simulation-based medical education.

SINGAPORE, Nov. 6, 2025 /PRNewswire/ — The first healthcare simulation certification programmes designed specifically for Southeast Asian professionals were launched at the S3 Conference 2025 opening ceremony today. The event was attended by Mr Tan Kiat How, Senior Minister of State, Ministry of Digital Development and Information & Ministry of Health. The Certified Educator in Healthcare Simulation (CEHS) and Certified Technologist in Healthcare Simulation (CTHS) programmes will provide accessible, rigorous training for doctors, nurses, allied health professionals and technical specialists across the region.

As current international certifications are based on American contexts, these affect the learning experience of participants in Southeast Asia and, consequently, the pass rates. Currently, the pass rates for participants based outside the United States for the Certified Healthcare Simulation Educator and the Certified Healthcare Simulation Operations Specialist programmes are at 14.6% and 15% respectively^[1]. The new CEHS and CTHS programmes seek to address the critical gaps in professional development for regional simulation professionals by offering contextualised content for Southeast Asian healthcare settings, scheduling that accommodates Southeast Asian time zones, and with lower costs compared to existing international certifications. Both programmes will commence by the end of 2026, with the goal of training 50 participants in the inaugural year. There are plans to scale up the intake over five years to meet growing regional demand.

The key benefits of the new certification programmes are as follows:

• Contextualised examination content reflecting Southeast Asian healthcare realities
• Training scheduled for Southeast Asian time zones
• Reduced costs for participants through regional development and delivery
• Enhanced technical expertise for simulation equipment operation
• Improved patient safety through better-trained healthcare professionals

Professor Lim Soon Thye, Deputy Group CEO (Research, Education & Innovation), SingHealth, said, “Healthcare simulation has become an essential aspect of training for a spectrum of clinical conditions, enabling healthcare professionals to master complex procedures and hone critical decision-making skills in a risk-free environment. As patient volume increases, with a growing number of complex cases, simulation-based education has become an important pedagogy in developing highly skilled practitioners not just in Singapore but across the region. I am confident that the new CEHS and CTHS programmes will support the growth of the use of healthcare simulation in medical education in Singapore and the region.”

The certification programmes were developed through collaboration between SingHealth Duke-NUS Institute of Medical Simulation, the Pan Asia Simulation Society in Healthcare, and the Malaysian Society for Simulation in Healthcare.

More information on the programmes can be found in the Annex.

About the S3 Conference

Hosted by the SingHealth Duke-NUS Institute of Medical Simulation (SIMS) and jointly organised with Society for Simulation in Europe (SESAM) and the Gathering of Healthcare Simulation Technology Specialists (SimGHOSTS), the S3 Conference 2025 is held from 5 to 7 November at the Ngee Ann Kongsi Auditorium, Academia, Singapore General Hospital Campus. Gathering the brightest minds and ideas in healthcare simulation, the highly anticipated conference will showcase the wide spectrum of healthcare simulation capabilities and applications pertinent across various domains of education today, with the aim of strengthening the practice of healthcare professionals to propel patient care standards in anticipation of future needs.

For more information, visit: https://www.singhealthdukenus.com.sg/S3-2025

About SingHealth Duke-NUS Academic Medical Centre

The SingHealth Duke-NUS Academic Medical Centre (AMC) draws on the collective strengths of SingHealth and Duke-NUS Medical School to provide our patients and community with the best outcomes and experience.

By leveraging the synergies in clinical care, research and education created through our Academic Clinical Programmes, Disease Centres and Joint Institutes, the SingHealth Duke-NUS AMC fosters the exchange of scientific knowledge and clinical perspectives to accelerate innovation and new discoveries, advance the practice of medicine as well as nurture the next generation of healthcare professionals.

SingHealth delivers comprehensive, multi-disciplinary and integrated care across a network of acute hospitals, national specialty centres, polyclinics and community hospitals. Offering over 40 clinical specialties, SingHealth is Singapore’s largest public healthcare cluster.

Duke-NUS, Singapore’s flagship graduate-entry medical school, nurtures ‘Clinician Plus’ graduates to become leaders in the global healthcare and biomedical ecosystem, while scientists from its five Signature Research Programmes and 10 Centres transform medicine and improve lives in Asia and beyond.

For more information, please visit:

www.singhealthdukenus.com.sg 
www.singhealth.com.sg
www.duke-nus.edu.sg

^[1]Pass rates for Southeast Asian participants are not available. 

ANNEX

Details of Southeast Asian Healthcare Simulation Certification Programmes

Background

The Certified Educator in Healthcare Simulation (CEHS) and Certified Technologist in Healthcare Simulation (CTHS) programmes are developed to directly address the limited access and progress to professional development for simulation professionals in Southeast Asia and the region.

Advantages

1)    Contextualised content

• Current international certifications are often based on the American contexts, including education systems, regulations, technical jargon and the use of colloquial language.
• Clinical settings may also differ between Asia and the West.
• These factors can cause confusion for Asian participants and pose challenges to effective learning.

2)    Southeast Asian-friendly scheduling

• Participants from Southeast Asia currently attend the review courses conducted in the USA in vastly different time zones (e.g. American courses are conducted at 3am Singapore time).

By providing training in a Southeast Asian time zone, participants do not have to sacrifice sleep and will be able to learn more effectively.

3)    Lower costs

• Programmes that are developed locally and regionally will enable training costs to be reduced for participants.
• This will lower the financial barriers to entry so that more Asian healthcare professionals can be equipped with the skills and knowledge they need.

Expected Impact on Healthcare Delivery

4)    Enhancing skills for improved patient outcomes

• More participants will be able to benefit from training methodology that focuses on experiential and hands-on learning that augments theoretical knowledge.
• Enhanced knowledge and skills will enable healthcare professionals to provide care that is safer and more effective.

5)    Advancing the role of simulation in medical education

• Healthcare simulation provides optimal learning environments for educators and learners, enabling them to hone their skills in a safe environment that provides high-fidelity clinical realism without risk to patients.
• The growth of the use of simulation in medical education enables educators and technologists to advance technical expertise to foster wider adoption.
• In turn, this elevates the quality of simulation-based medical education and training.

With the new CEHS and CTHS programmes, healthcare educators and simulation technologists will be equipped with validated simulation competencies and be well-positioned to deliver healthcare simulation within the Asian context, while upholding rigorous international quality and safety standards.

Photo